These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Cataract-causing variant Q70P damages structural stability of βB1-crystallin and increases its tendency to form insoluble aggregates.
    Author: Zhang Y, Ren L, Wu W, Liu J, Tian Q, Yao K, Yu Y, Hu L, Chen X.
    Journal: Int J Biol Macromol; 2023 Jul 01; 242(Pt 2):124722. PubMed ID: 37148932.
    Abstract:
    Congenital cataract is the primary cause of childhood blindness worldwide. As the predominant structural protein, βB1-crystallin plays an important role in maintaining lens transparency and cellular homeostasis. Numerous cataract-causing mutations of βB1-crystallin have been identified with unclear pathogenic mechanism. We previously identified the mutation Q70P (Q to P at residue position 70) of βB1-crystallin linked to congenital cataract in a Chinese family. In this work, we investigated the potential molecular mechanism of βB1-Q70P in the congenital cataract at the molecular, protein, and cellular levels. We purified recombinant βB1 wild-type (WT) and Q70P proteins and compared their structural characteristics and biophysical properties by spectroscopic experiments under physiological temperature and environmental stresses (ultraviolet irradiation, heat stress, oxidative stress). Notably, βB1-Q70P significantly changed the structures of βB1-crystallin and exhibited lower solubility at physiological temperature. Meanwhile, βB1-Q70P was prone to aggregation in eukaryotic and prokaryotic cells, and was more sensitive to environmental stresses, along with impaired cellular viability. Furthermore, the molecular dynamics simulation indicated that the mutation Q70P damaged secondary structures and hydrogen bond network of βB1-crystallin, which were essential for the first Greek-key motif. This study delineated the pathological mechanism of βB1-Q70P and provided novel insights into treatment and prevention strategies for cataract-associated βB1 mutations.
    [Abstract] [Full Text] [Related] [New Search]